399 related articles for article (PubMed ID: 23169309)
1. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
3. Inflammation in sporadic colorectal cancer.
Moossavi S; Bishehsari F
Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
[TBL] [Abstract][Full Text] [Related]
4. IBD-related carcinoma and lymphoma.
Claessen MM; Siersema PD; Vleggaar FP
Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S27-38. PubMed ID: 21640928
[TBL] [Abstract][Full Text] [Related]
5. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
7. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.
Waldner MJ; Neurath MF
Semin Immunol; 2014 Feb; 26(1):75-9. PubMed ID: 24447345
[TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
10. Dysplasia and cancer in inflammatory bowel disease.
Basseri RJ; Basseri B; Papadakis KA
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
[TBL] [Abstract][Full Text] [Related]
11. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
Yashiro M
Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.
Goel GA; Kandiel A; Achkar JP; Lashner B
Am J Gastroenterol; 2011 Apr; 106(4):719-30. PubMed ID: 21386829
[TBL] [Abstract][Full Text] [Related]
13. Mucins in inflammatory bowel diseases and colorectal cancer.
Sheng YH; Hasnain SZ; Florin TH; McGuckin MA
J Gastroenterol Hepatol; 2012 Jan; 27(1):28-38. PubMed ID: 21913981
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
15. [The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine].
Broom OJ; Nielsen OH
Ugeskr Laeger; 2009 Jan; 171(4):243-6. PubMed ID: 19174041
[TBL] [Abstract][Full Text] [Related]
16. Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology.
Matkowskyj KA; Chen ZE; Rao MS; Yang GY
Arch Pathol Lab Med; 2013 Mar; 137(3):338-50. PubMed ID: 23451745
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
18. Large Bowel Genetic Background and Inflammatory Processes in Carcinogenesis--Systematic Review.
Szylberg Ł; Janiczek M; Popiel A; Marszałek A
Adv Clin Exp Med; 2015; 24(4):555-63. PubMed ID: 26469098
[TBL] [Abstract][Full Text] [Related]
19. Cancer surveillance in inflammatory bowel disease: new molecular approaches.
Risques RA; Rabinovitch PS; Brentnall TA
Curr Opin Gastroenterol; 2006 Jul; 22(4):382-90. PubMed ID: 16760754
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
Herszényi L; Barabás L; Miheller P; Tulassay Z
Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]